ERBB3 and neoplasm: To examine the efficacy of the combined treatment of anti‐HER3 and anti‐MET drugs against human CRC cells, we evaluated the effects of patritumab and PHA665752 against SW1116 cells using in vitro colony formation in 3D‐culture and in vivo tumor growth in nude mice.